中华超声影像学杂志
中華超聲影像學雜誌
중화초성영상학잡지
CHINESE JOURNAL OF ULTRASONOGRAPHY
2009年
1期
52-54
,共3页
王晻%梁萍%于晓玲%张大鹍%高永艳%任贺
王晻%樑萍%于曉玲%張大鹍%高永豔%任賀
왕엄%량평%우효령%장대곤%고영염%임하
超声检查%肾肿瘤%微波/治疗应用
超聲檢查%腎腫瘤%微波/治療應用
초성검사%신종류%미파/치료응용
UItrasonography%Kidney neoplasms%Microwaves/therapeutic use
目的 探讨超声引导经皮微波消融肾肿瘤的安全性和临床疗效.方法 22例肾肿瘤患者(22个病灶),其中肾癌18例,肾血管平滑肌脂肪瘤3例,肾嗜酸细胞腺瘤1例.肿瘤直径1.0~3.8 cm.治疗时在超声引导下将水冷式微波天线植入肿瘤内,瘤周放置测温针实时监测温度,肿瘤直径小于2 cm者使用一根微波天线,肿瘤直径大于2 cm者使用2根微波天线.微波消融后3 d内行超声造影观察有无残存肿瘤,造影无肿瘤残存者治疗后1、3、6个月,随后每6个月行增强CT/MR或超声造影评价肿瘤的治疗效果.结果 20例病灶在一次消融后完全坏死,2例病灶在二次消融后完全坏死,微波消融无严重并发症出现,随访期内未发生肿瘤复发、转移.结论超声引导经皮微波消融肾肿瘤安全有效,副作用小,是治疗局限性肾肿瘤的有效方法.
目的 探討超聲引導經皮微波消融腎腫瘤的安全性和臨床療效.方法 22例腎腫瘤患者(22箇病竈),其中腎癌18例,腎血管平滑肌脂肪瘤3例,腎嗜痠細胞腺瘤1例.腫瘤直徑1.0~3.8 cm.治療時在超聲引導下將水冷式微波天線植入腫瘤內,瘤週放置測溫針實時鑑測溫度,腫瘤直徑小于2 cm者使用一根微波天線,腫瘤直徑大于2 cm者使用2根微波天線.微波消融後3 d內行超聲造影觀察有無殘存腫瘤,造影無腫瘤殘存者治療後1、3、6箇月,隨後每6箇月行增彊CT/MR或超聲造影評價腫瘤的治療效果.結果 20例病竈在一次消融後完全壞死,2例病竈在二次消融後完全壞死,微波消融無嚴重併髮癥齣現,隨訪期內未髮生腫瘤複髮、轉移.結論超聲引導經皮微波消融腎腫瘤安全有效,副作用小,是治療跼限性腎腫瘤的有效方法.
목적 탐토초성인도경피미파소융신종류적안전성화림상료효.방법 22례신종류환자(22개병조),기중신암18례,신혈관평활기지방류3례,신기산세포선류1례.종류직경1.0~3.8 cm.치료시재초성인도하장수랭식미파천선식입종류내,류주방치측온침실시감측온도,종류직경소우2 cm자사용일근미파천선,종류직경대우2 cm자사용2근미파천선.미파소융후3 d내행초성조영관찰유무잔존종류,조영무종류잔존자치료후1、3、6개월,수후매6개월행증강CT/MR혹초성조영평개종류적치료효과.결과 20례병조재일차소융후완전배사,2례병조재이차소융후완전배사,미파소융무엄중병발증출현,수방기내미발생종류복발、전이.결론초성인도경피미파소융신종류안전유효,부작용소,시치료국한성신종류적유효방법.
Objective To evaluate the safety and efficacy of ultrasound-guided percutaneous microwave ablation of renal neoplasms.Methods Twenty-two patients with pathologically proven renal neoplasms(18 renal cell carcinoma,3 renal angiomyolipoma,1 oncocytoma)with diameters of 1.0 to 3.8 cm were treated by microwave ablation.Cooled-shaft needle antenna was percutaneously inserted into the tumors under ultrasound guidance.One antenna was used for tumors less than 2 cm,two antennas were used for tumors larger than 2 cm.One thermal couple was placed adjacent to the tumor monitoring temperature in real-time during ablation.Immediate treatment efficacy was assessed by contrast-enhanced ultrasound within 3 days after ablation.Short-term efficacy was assessed by contrast-enhanced CT and/or contrast-enhanced ultrasound at 1,3,6 months and every 6 months thereafter.Results Twenty tumors were completely ablated in a single session,2 tumors were completely ablated in 2 sessions.No complications occurred.No residual tumor or recurrence was observed during follow-up.Conclusions Ultrasound-guided pereutaneous microwave ablation appears to be a safe and effective technique for the management of renal neoplasms in selected patients.